9H-indeno[1,2-b]pyrazine derivatives
US5468748A · kind A · utility
1Cited by
6References
12Claims
0Family size
Inventors
Key dates
| Filing date | Jan 31, 1994 |
| Grant date | Nov 21, 1995 |
| Priority date | — |
| Expiry date | Jan 31, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/650994
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.